• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒相关疾病免疫预防专家共识(节略版)

[Expert consensus on immunological prevention of human papillomavirus-related diseases (abridged)].

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Dec 10;40(12):1499-1516. doi: 10.3760/cma.j.issn.0254-6450.2019.12.002.

DOI:10.3760/cma.j.issn.0254-6450.2019.12.002
PMID:32062907
Abstract

Human papillomavirus (HPV)-related diseases such as cervical cancer are public health problems that threaten human health. In response to an action plan for the elimination of cervical cancer, we review the etiology, clinical features, and epidemiology of HPV-related diseases and HPV vaccinology. Our consensus statement is based on the World Health Organization position paper on HPV vaccines (2017) and on recent advances in Chinese and international HPV research. Its purpose is to strengthen HPV-related disease prevention and control by providing systematic, comprehensive evidence to enable health professionals use of HPV vaccine in a scientifically-appropriate manner that maximizes impact on disease.

摘要

人乳头瘤病毒(HPV)相关疾病,如宫颈癌,是威胁人类健康的公共卫生问题。为响应消除宫颈癌的行动计划,我们回顾了HPV相关疾病的病因、临床特征、流行病学以及HPV疫苗学。我们的共识声明基于世界卫生组织关于HPV疫苗的立场文件(2017年)以及中国和国际HPV研究的最新进展。其目的是通过提供系统、全面的证据,加强HPV相关疾病的预防和控制,使卫生专业人员能够以科学适当的方式使用HPV疫苗,从而最大限度地对疾病产生影响。

相似文献

1
[Expert consensus on immunological prevention of human papillomavirus-related diseases (abridged)].人乳头瘤病毒相关疾病免疫预防专家共识(节略版)
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Dec 10;40(12):1499-1516. doi: 10.3760/cma.j.issn.0254-6450.2019.12.002.
2
[Expert consensus on immunoprophylaxis of human papillomavirus-related diseases (abridged)].人乳头瘤病毒相关疾病免疫预防专家共识(节略版)
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Dec 6;53(12):1218-1235. doi: 10.3760/cma.j.issn.0253-9624.2019.12.006.
3
[Expert consensus on immunological prevention of human papillomavirus-related diseases].[人乳头瘤病毒相关疾病免疫预防专家共识]
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Aug 6;53(8):761-803. doi: 10.3760/cma.j.issn.0253-9624.2019.08.001.
4
[Human papillomavirus infection and vaccination].[人乳头瘤病毒感染与疫苗接种]
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Jan 6;52(1):106-112. doi: 10.3760/cma.j.issn.0253-9624.2018.01.021.
5
Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).预防人免疫缺陷病毒(HIV)感染者的人乳头瘤病毒(HPV)相关肿瘤。
Expert Rev Anti Infect Ther. 2017 Nov;15(11):987-999. doi: 10.1080/14787210.2017.1392854. Epub 2017 Oct 20.
6
Cervical Cancer, Human Papillomavirus Infection, and Vaccine-Related Knowledge: Awareness in Chinese Women.宫颈癌、人乳头瘤病毒感染与疫苗相关知识:中国女性的知晓情况
Cancer Control. 2018 Jan-Dec;25(1):1073274818799306. doi: 10.1177/1073274818799306.
7
Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.美国男女性生殖器人乳头瘤病毒感染率和疫苗接种率的差异。
Future Oncol. 2017 Jun;13(13):1129-1132. doi: 10.2217/fon-2017-0147. Epub 2017 Jun 7.
8
The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment.人乳头瘤病毒疫苗在宫颈癌中的作用:预防和治疗。
Crit Rev Oncol Hematol. 2018 Feb;122:92-97. doi: 10.1016/j.critrevonc.2017.12.017. Epub 2017 Dec 28.
9
Human papillomavirus vaccination acceptance and hesitancy in South Africa: Research and policy agenda.南非的人乳头瘤病毒疫苗接种接受度和犹豫:研究和政策议程。
S Afr Med J. 2018 Dec 13;109(1):13-15. doi: 10.7196/SAMJ.2018.v109i1.13723.
10
Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report.全球疫苗免疫联盟(GAVI)国家的人乳头瘤病毒(HPV)及相关癌症。一份世界卫生组织/国际癌症研究机构HPV信息中心报告。
Vaccine. 2012 Nov 20;30 Suppl 4:D1-83, vi. doi: 10.1016/S0264-410X(12)01435-1.

引用本文的文献

1
Long-term protective efficacy of the produced HPV-16/18 bivalent human papillomavirus vaccine in women vaccinated at 18-45 years: A 9-year follow-up study.所生产的HPV-16/18二价人乳头瘤病毒疫苗对18至45岁女性的长期保护效力:一项9年随访研究。
Infect Med (Beijing). 2025 Jan 10;4(1):100164. doi: 10.1016/j.imj.2025.100164. eCollection 2025 Mar.
2
Prevalence and genotype distribution of human papillomavirus infection among women in Jingzhou, China: a population-based study of 51,720 women.中国荆州地区女性人群人乳头瘤病毒感染的流行率及基因型分布:一项基于人群的 51720 例女性研究。
Virol J. 2023 Dec 15;20(1):297. doi: 10.1186/s12985-023-02262-1.